Surging demand for chromatography technology from various research &
development, and diagnostics industries will drive growth of the
global chromatography
resins market. Future Market Insights (FMI), in its report,
projects the market to register an impressive 8.9% CAGR during the
forecast period 2017 to 2027. In 2016, the market was evaluated at
revenue worth US$ 719 Mn; by 2027-end it is estimated to reach nearly
US$ 2,000 Mn. The global chromatography resins market is anticipated
to witness an incremental opportunity of over US$ 1,000 Mn between
2017 and 2027.
Research laboratories and biopharmaceutical companies in North
America are increasingly focusing on enhancements in automation of
sample handling processes. This is expected to drive demand for high
throughput advanced chromatography columns and media, thereby
fostering the market growth in this region. In addition, soaring
advancements in chromatography technologies for separation &
purification of complex bio-substances and bio-molecules will further
boost demand for high-end, advanced chromatography resins in North
America. However, stringent rules & regulations imposed by the
U.S. FDA on new product launches is likely to hinder growth of the
market in North America.
Cost-effective purification technology is being highly implemented in
Western Europe for separation of enantiomers, isomers and several
active pharmaceutical ingredients. This further promotes purity and
offers higher productivity to biopharmaceutical industries, which in
turn will drive growth of the global chromatography resins market in
this region. In addition, increasing availability and demand for
branded resin products, which are more costly, are other factors
expected to fuel growth of the market in Western Europe. In contrast,
continuous evaluations and improvements in novel alternatives to
chromatography resins are estimated to impede the market growth in
this region.
Request to view table of content @
North America will remain the largest market for chromatography
resins, with sales expected to reach nearly US$ 600 Mn by 2027-end,
followed by Western Europe and Asia Pacific Excluding Japan (APEJ).
In addition, APEJ is estimated to register fastest expansion at 9.4%
CAGR through 2027. Although Middle East & Africa (MEA) accounts
for lowest share of the market, this region is expected to be the
second-fastest growing market for chromatography resins by 2027-end.
By product type, synthetic chromatography resins are expected to
remain preferred in the market, with sales expanding at 9.1% CAGR
through 2027. Revenue generated from sales of native chromatography
resins in the market will remain low during the forecast period.
Affinity chromatography will continue to be the most used technology
in the global chromatography resins market. Revenue amassed from
sales of affinity chromatography technology is expected to reach US$
679.6 Mn by 2027-end. Hydrophobic interaction chromatography
technology and affinity chromatography technology are expected to
exhibit parallel expansion at 9.3% CAGR through 2027.
Biopharmaceutical companies will remain the largest end-users of
chromatography resins across the globe, followed by academic
institutes. Sales of chromatography resins to biopharmaceutical
companies is projected to register 9.2% CAGR, to reach nearly US$ 800
Mn in revenue by 2027-end.
Key market players identified in FMI’s report include Agilent
Technologies, Bio-Rad Laboratories, Inc., GE Healthcare, Waters
Corporation, Expedeon Ltd., Thermo Fisher Scientific Inc., Pall
Corporation, Merck KGaA, PerkinElmer, Inc., Kaneka Corporation,
Shimadzu Corporation, Knauer GmbH, Tosoh Bioscience, Avantor
Performance Materials Inc., Mitsubishi Chemical Corporation, W.R.
Grace & Co., JSR Micro Inc., Life Technology Corporation.
Buy Chromatography Resin Market Report @
No comments:
Post a Comment